文献速递慢性肾脏病肾小球疾病

赖氨酰氧化酶样蛋白2促进Col4α3/Alport小鼠肾纤维化

Lysyl oxidase like-2 contributes to renal fibrosis in Col4α3/Alport mice.
PubMed 文献 · Kidney Int · 2018-05-16

该研究在COL4A3(-/-)Alport小鼠中使用选择性LOXL2小分子抑制剂或溶媒对照,评估肾小球硬化、纤维化、白蛋白尿、血尿素氮、寿命及肾小球基底膜超微结构。LOXL2抑制显著减少间质纤维化及MMP-2、MMP-9、TGF-β1、TNF-α mRNA表达,并减轻肾小球硬化、降低白蛋白尿和血尿素氮,但对寿命无影响。

要点

  • LOXL2抑制可减轻Alport小鼠肾小球硬化与间质纤维化
  • LOXL2抑制降低白蛋白尿和血尿素氮,但不延长寿命
  • LOXL2抑制减少多种促纤维化基因表达并改善GBM超微结构

核心结论

  • LOXL2在小鼠Alport综合征相关的肾小球和间质病变中起重要促进作用。

研究设计与样本

  • 研究使用COL4A3(-/-)Alport小鼠,分别给予选择性LOXL2小分子抑制剂或溶媒对照。
  • 评估指标包括肾小球硬化与纤维化、白蛋白尿、血尿素氮、寿命、促纤维化基因表达及肾小球基底膜超微结构。

主要发现

  • LOXL2抑制显著减少间质纤维化及MMP-2、MMP-9、TGF-β1、TNF-α的mRNA表达。
  • LOXL2抑制减少肾小球硬化、肾小球内MMP-10、MMP-12、MCP-1 mRNA表达,并降低白蛋白尿和血尿素氮。
  • LOXL2抑制减轻系膜细胞伪足侵入毛细血管簇、减少层粘连蛋白α2在肾小球基底膜的沉积,并使基底膜超微结构正常化。
  • LOXL2抑制对寿命无影响。

临床怎么用

  • 在Alport综合征相关肾纤维化中,LOXL2抑制可能减轻肾小球和间质病变,但未显示延长寿命。
  • 该发现提示LOXL2可能作为Alport综合征及其他慢性肾脏病纤维化的潜在治疗靶点。

局限性

  • 研究仅在小鼠模型中进行,尚未在人体验证。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Lysyl oxidase like-2 (LOXL2) is an amine oxidase with both intracellular and extracellular functions. Extracellularly, LOXL2 promotes collagen and elastin crosslinking, whereas intracellularly, LOXL2 has been reported to modify histone H3, stabilize SNAIL, and reduce cell polarity. Although LOXL2 promotes liver and lung fibrosis, little is known regarding its role in renal fibrosis. Here we determine whether LOXL2 influences kidney disease in COL4A3 (-/-) Alport mice. These mice were treated with a small molecule inhibitor selective for LOXL2 or with vehicle and assessed for glomerular sclerosis and fibrosis, albuminuria, blood urea nitrogen, lifespan, pro-fibrotic gene expression and ultrastructure of the glomerular basement membrane. Laminin α2 deposition in the glomerular basement membrane and mesangial filopodial invasion of the glomerular capillaries were also assessed. LOXL2 inhibition significantly reduced interstitial fibrosis and mRNA expression of MMP-2, MMP-9, TGF-β1, and TNF-α. LOXL2 inhibitor treatment also reduced glomerulosclerosis, expression of MMP-10, MMP-12, and MCP-1 mRNA in glomeruli, and decreased albuminuria and blood urea nitrogen. Mesangial filopodial invasion of the capillary tufts was blunted, as was laminin α2 deposition in the glomerular basement membrane, and glomerular basement membrane ultrastructure was normalized. There was no effect on lifespan. Thus, LOXL2 plays an important role in promoting both glomerular and interstitial pathogenesis associated with Alport syndrome in mice. Other etiologies of chronic kidney disease are implicated with our observations.

来源:Kidney Int,查看原文。版权归原作者所有。

引用

  1. Cosgrove D, Dufek B, Meehan DT, et al. Lysyl oxidase like-2 contributes to renal fibrosis in Col4α3/Alport mice. Kidney Int. 2018. PMID: 29759420. doi:10.1016/j.kint.2018.02.024

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。